Chicken anemia virus (CAV) is the causative agent of chicken infectious anemia (CIA). Studying CAV isolates in Egypt and their genetic diversity and its potential role in vaccination failure recently noticed in broiler flocks, is lacking in Egypt. So, the present study aimed to characterize CAV isolate-collected from a commercial broiler flock suffered from severe anemia and high mortality based on sequence and phylogenetic analysis of partial VP1 gene as well as to study pathogenicity and immunosuppressive potential in one day-old SPF chicks. The CAV isolate proved to be positive by PCR. The PCR product was sequenced and submitted to the gene bank under the accession number KX171350 and the CAV strain was designated as CLEVB-Zag2. Phylogenetic analysis at the nucleotide and amino acids level classify CLEVB-Zag2 CAV under group III (genotype III) of CAVs. On the other hand, the CLEVB-Zag2 CAV was found to be highly pathogenic for the experimentally inoculated SPF-chicks showing depression, severe anemia in almost all chicks in two infected groups beginning at the 7th day post infection (PI) and reached the peak of severity at the 14th day (hematocrit value, hemoglobin conc. and RBCs counts) are significantly reduced in chicks of the infected group. Blue wings were observed in few chicks in each infected group at the 14th day PI. Macroscopic lesions consisting of subcutaneous and muscular hemorrhages are observed with pale bone marrow, significant atrophy of thymus, spleen and bursa, hepatomegally with mottled liver and paleness of the carcasses were detected 7 days PI Those findings were evident and increased in severity until the day 14 PI. Concerning the CLEVB-Zag2 CAV, it was found to be highly immunosuppressive in the infected SPFchicks vaccinated with a commercial potent inactivated H5N1 vaccine as manifested by a significant reduction (protection 50%). The variance in the titer of the shieded challenge H5N1 virus was 1.45 log10 and the mean HI titer at the 4th week post vaccination was 1.5 log2 compared with the non-infected vaccinated group where these values were 90%, 2.35 log10 and 5.3 log2; respectively. In conclusion, the present study revealed that the CLEVB-Zag2 CAV isolate is highly pathogenic and immunosuppressive.
Introduction
Chicken anemia virus (CAV) is a ubiquitous and highly resistant virus of chickens that causes anemia and death in chicks less than 3 weeks of age and immune suppression in chickens older than 3 weeks of age (Miller et al., 2003) . CAV is a small spherical, non-enveloped virus containing a circular single stranded DNA genome (Pope, 1991) .
CAV was recorded in different countries allover the world (England, Mexico, Belgium, Brazil, Taiwan, Argentina, China, Israel, Nigeria, Greece, Malaysia, New Zealand, Iran, Turkey and India (Pope, 1991 , Yong et al., 1993 Buscaglia et al., 1994; Zhou et al., 1997; Ledesma et al., 2001; Davidson et al., 2004; Oluwayelu et al., 2005; Bougiouklis et al., 2007; Hailemariam et al., 2008) .
CAV infection in chickens is characterized by severe anemia, intramuscular hemorrhage, destruction of RBCs in the bone marrow, low hematocrite value and reduced body weight. CAV is an immunosuppressive agent and its major pathological effect is seen in the thymus (Pope, 1996) .
The present study was planned to fulfill the following Detection of CAV in suspected field samples by PCR assay, Molecular characterization of the predicted isolate detected by PCR using gene sequencing followed by phylogenesis, Studying the pathogenicity of the predicted isolate of CAV in one day old SPF chicks and Studying the potential immune-suppression of the isolated CAV in chickens vaccinated with inactivated AI vaccine, via determining the post vaccination immune response (HI), and the protection percentage in both vaccinated infected and vaccinated non infected groups.
Materials and methods Chicken Anemia Virus isolate
Thymus glands were collected from a 30 day old broiler chickens flock suffered from severe anemia and stunting. The thymuses were ground with PBS (pH 7.2) containing 1000 IU/ml penicillin and 10 mg streptomycin at 2/10 (W/V) and subjected to 3 cycles of freezing and thawing, centrifuged and filtered through 0.45 micron millipore filter. The filtrate was kept at -20 ºC till used.
DNA Extraction and PCR Amplification
Viral DNA was extracted from the filterate by QIAamp DNA mini kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. The primers 5 ' -GAC TGT AAG ATG GCA AGA CGA GCT C-3 ' and 5 ' -GGC TGA AGG ATC CCT CAT TC-3' were used to amplify a 675 bp DNA fragment of VB1 (Todd et al., 1995) . The PCR assay was performed using 2X Master mix (Biomatik company cat. number A4145lot number 067) kit according to the manufacturer's instructions in a final volume of 50 µl Brefly,25 µl of the master mix, 18 µl PCR grade water, 1 µl of each primer, and 5 µl template. The PCR conditions were: one cycle of initial denaturation at 94 º C for 5 min followed by 34 cycles of 94 º C for 1 min, 56 º C for 1 min, and 72 º C for 1 min. and finally one cycle of final extension at 72 º C for 7 min.
Sequencing and phylogenetic analysis
The PCR product was submitted to a commercial company (Sigma) to be sequenced in both directions. The obtained sequence was submitted to the Gene Bank and the isolate was designated as CLEVB-Zag2 CAV under the accession number KX171350. Phylogenetic analysis was done using DNA star version 6.
Avian influenza vaccine and challenge highly pathogenic avian influenza (HPAI) H5N1 virus
A commercial inactivated oil adjuvenated H5N1 AI vaccine was used for vaccination of experimental chicks.
HPAI H5N1 virus strain A/duck/Egypt/CLEVB-24_N00238/2015 of accession number EPI579780 was supplied by CLEVB and used to challenge experimentally vaccinated chicks.
Chickens
One hundred, one-day-old specific pathogen-free (SPF) chickens free form CAV and CAV antibodies (Koum Osheim, Egypt) were divided into 3 groups each of 33 chicks and housed in BSL3 chicken isolators throughout an experimental period of 38 days.
Experimental design
On day one of age, each chick of group (1) and (2) was inoculated intra-muscular with 0.2 ml of the collected thymus homogenate, while chicks of group (3) were kept as non-inoculated negative control. At the 7th and 14th days post infection, 5 chickens were selected randomly from groups (1) and (3), clinically examined and weighed. Heparinized blood samples were obtained individually from the jugular vein for haematocrit values and the other hematological values. Subsequently, birds were euthanized and examined for gross-pathological changes. Liver, thymus, bursa and spleen were collected and weighed individually. Weights and hematological values were analyzed by a Fisher test. Samples were then obtained from each organ and fixed in 10% buffered formalin for histopathological examination. Additional samples were obtained and stored frozen for virus detection by PCR. At the 14 th day of age, chicks of groups (1) and (2) were vaccinated against avian influenza using 0.5 ml of a commercial H5N1 AI vaccine via the subcutaneous route. Blood samples were collected randomly from 10 chickens of each group weekly till the 4 th week post vaccination; where 20 chickens from each group were challenged via the intranasal rout with 0.1 ml of the 2015 HPAI H5N1 virus strain (A/duck/Egypt/CLEVB-24_N00238/2015 of accession number EPI579780). Challenged chickens were observed for 10 days, both clinical signs, morbidity and mortalities were recorded. Oropharyngeal swabs were collected individually for detection of virus shedding, from the chickens of each challenged group at the 3rd, 5th, 7th and 10th days post challenge.
HPAI virus shedding detection and quantification
Swabs samples were resuspended in 1ml PBS containing 1000 IU penicillin and 1000ug streptomycin by cutting the cotton part in cryo-vial and doing vigorous vortexing. Supernatant fluids were transferred to new vials then viral RNA extraction was done using Qiagen RNase extraction kit according to the manufacturer's instructions, then real time Rt-PCR were conducted using Real time RT-PCR kit (Invitrogen, USA). The primers, probe and cycle conditions were according to Löndt et al. (2008) . The shedding titer (PCR copies/ml) was conducted targeting the M gene and results of CT values were calculated against challenge virus standard curve. Mean shedding titer= sum of shedding titers/number of shedder birds.
Heamagglutination and heamagglutination inhibition (HA and HI) tests
The post vaccination chicken immune response monitoring was conducted using HI test according to OIE Manual (2013), using standard 4 HAU of the homologous antigen. Data of HI testing were analyzed based on geometric mean titer and standard deviation (SD).
Histopathology
Liver, spleen, thymus and bone marrow samples of birds in different groups were fixed in 10% formol-saline until histopathological examination and stained by hematoxylin and eosin then examined through the light electric microscope according to Bancroft et al. (1996) .
Results Clinical signs and PM of the affected broiler flock
The examined broiler flock showed depression and paleness (Anemia), uneven growth with high mortality (60%) which start at the 18 th day of age and continued till the slaughter time (35 th day of age). Dead birds showed atrophied thymus and bursa, enlarged and mottled liver, subcutaneous and muscular hemorrhages, fatty and yellowish bone marrow of the femur and finally skin lesions "blue wings disease" (Figs. 1-4 ).
PCR result
The 675 bp amplicon of the VP1 of CAV was detected by PCR in the thymus homogenate of the examined broiler flock indicating CAV infection (Fig. 5 ). The PCR product was sequenced and submitted to the gene bank under the accession number KX171350 and the CAV strain was designated as CLEVB-Zag2.
Phylogenetic analysis
Phylogenetic analysis at the nucleotide and amino acid levels classify CLEVB-Zag2 CAV under group III (Genotype III). On the other hand, the CLEVB-Zag2 CAV was found to be 100% identical to 2 CAV from India of accession numbers KJ620993 and KJ620995 and one CAV isolate from South Korea of accession number HM018735 and Finally the vaccinal strain Noblis P4.
Pathogenicity
Clinical signs in the form of depression, anorexia, dehydration, uneven growth and anemia were observed on almost all chicks in the two infected groups beginning at the 7 th day post infection (PI) and reached the peak of severity at the 14 th PI (Hematocrit value, Hemoglobin conc. and RBCs counts are significantly reduced in the chicks of the infected group (Table 1) . Blue wings were observed on few chicks in each infected group at the 14 th day PI, at the same period, macroscopic lesions in the form of subcutaneous and muscular hemorrhages were observed with pale bone marrow, significant atrophy of thymus, spleen and bursa, hepatomegally with mottled liver and paleness of the carcasses were detected 7 days p.i. These findings were evident until day 14 PI where it increased in severity (Figs. 6-9 and Table 2) .
Microscopically, after 7 days, the portal area of the liver of the experimental chicks showed severe congestion in the portal vein associated with focal necrosis as well as inflammatory cells infiltration ( Fig. 10A and 10B) . The thymus showed lymphoid depletion in both cortical and medullary portions with congestion in the blood vessel (Fig. 10C) . The spleen showed lymphoid depletion in the white pulps while the red one had congestion (Fig. 10D) . Finally, the bone marrow showed severe depletion in the erythrocytes as well as the other haemoblasts ( Fig. 10E) . At the 14th day PI, focal lymphoid cell aggregations were detected in the hepatic parenchyma ( Fig. 11A) with sever dilatation and congestion in the portal vein (Fig. 11B ).In the thymus, there was depletion in both cortical and medullary lymphoid structure (Fig. 11C) .The spleen showed focal necrosis in diffuse manner allover the white pulps (Fig. 11D) .Finally, the Bone marrow showed sever depletion in diffuse manner allover the erythrocytes as well as the haemoblasts with inflammatory cells infiltration (Fig. 11E ).
Immunosuppressive potential
Severe immunosuppression was detected in the CAV infected SPF chicken group as manifested by significant reduction in the protection percentage (50%), the variance in the titer of the shielded challenge H5N1 virus (1.45 log10) and the mean HI titer at the 4 th week PV (1.5 log2) compared with the non-infected vaccinated group where these values were 90%, 2.35 log10 and 5.3 log2, respectively (Tables 3-5).
Discussion
CAV has been reported to cause disease in young chicks aged one day to 4 weeks. In older chickens CAV infection has been reported to be subclinical (McNulty, 1991) . The present examined broiler flock showed anemia, uneven growth with high mortality (60%) which start at the 18 th day of age and continued till the slaughter time (35 th day of age).The dead birds showed atrophied thymus and bursa, enlarged and mottled liver, subcutaneous and muscular hemorrhages, fatty and yellowish bone marrow of the femur and finally skin lesions "blue wings disease" (Figs.1-4) . These results are similar to those of Yuasa et al., (1979 , 1987 ), von Bülow et al. (1983 , 1986 , McNulty et al. (1989 McNulty et al. ( , 1990 , McNulty (1991) and Noteborn et al. (1991 Noteborn et al. ( , 1992 . In the same context the observed high mortalities in the examined flock could be due to the immunosuppressive effect of CAV that lead to vaccination failure and aggravation of the pathogenicity of other avian pathogens (secondary infections), as reported by Von Bülow et al. (1986) , Yuasa et al. (1987 ), Engström (1988 , Otaki et al. (1988) , Rosenberger and Cloud (1989), de Boer et al. (1992) , McNulty et al. (1991) , McIlroy et al. (1992) , Jeurissen and de Boer (1993) , Sommer and Adair (2000) , Cardona (2003) and Davidson et al. (2004) .
CAV was detected by PCR in the examined broiler flock and the amplified PCR product, which represent partial VP1 gene, was sequenced and the CAV strain was designated as CLEVB-Zag2 with accession number KX171350 at the gene bank. Phylogenetic analysis at the amino acids and nucleotide level of VP1 classify CLEVB-Zag2 CAV under group III (Genotype III) of the CAV in agreement with Islam et al. (2002) , Ducatez et al. (2006 Ducatez et al. ( , 2008 , Craig et al. (2009 ), Kim et al. (2010 and Snoeck et al. (2012) .
On the other hand, the CLEVB-Zag2 CAV was found to be 100% identical to 2 CAV of high virulence from India of accession numbers KJ620993 and KJ620995 and one CAV isolate of high virulence from South Korea of accession number HM018735 and finally, the vaccinal strain Noblis P4.
The obtained results of pathogenecity studies of CLEVB-Zag2 CAV in one day old SPF chicks showed high virulence in the form of retardation of body weight gain and sever anaemia. Lowest body weights and haematocrite values were detected 7 th and 14 th days PI the histopathological lesions detected in thymus, bursa, spleen, liver and bone marrow were similar in frequency at days 7 and 14 PI indicating sever destruction of the lymphoid tissue. The weights of thymus and bursa were substantially reduced compared to the noninoculated birds at day 7 and day 14 PI these findings agreed with the findings of Toro et al. (1997) .
Studying the immunosuppressive potential of the CLEVB-Zag2 CAV on the immune response of SPF chicks against H5NI vaccine, the results indicated that our isolate was highly virulent and induce significant reduction in the protection percentage (50%), the variance in the titer of the shed challenge H5N1 virus (1.45 log10) and the mean HI titer at the 4 th week PV (1.5 log2) compared with the noninfected vaccinated group where 90%, 2.35 log10 and 5.3 log2 for the protection percentage, variance in the titer of the sheded challenge H5N1 virus and Mean HI titer; respectively (Tables 3-5). Our results agreed with those obtained by Hagood et al. (2000) , Senthilkumar et al. (2002) , Miller and Schat (2004) , Dhama et al. (2008) and Hoerr (2010) who reported that infections with CAV generally cause severe and acute clinical disease in young chicks up to 3-4 weeks of age, after which age resistance to clinical infection has been reported to develop. Sub-clinical and persistent latent viral infections occurring in adult broiler and layer chickens are associated with production losses and vaccination failures.
In the same context, we could attribute this reduction in the immune response (vaccination failure)-in the experimental group infected with CAV to the sever destruction of the lymphoid tissue specially thymus, almost same explanation was recorded (Box et al., 1988) , who stated that the effect on the thymus may be the underlying cause of the impaired response to inactivated Newcastle disease vaccine. The Same findings were recorded by de Boer et al. (1994) who stated that the aggravating effect of CAV on other viruses is mainly caused by impairment of other T-cell-mediated immune functions (other than T-helper cells),which leads to enhancing or transactivating of the virus replication of the other virus. Fig. 10. Histopathological findings of the liver. A & b) showed severe congestion in the portal vein associated with focal necrosis as well as inflammatory cells infiltration. C) Thymus showed lymphoid depletion in both cortical and medullary portions with congestion in the blood vessel. D) Spleen showed lymphoid depletion in the white pulps while the red one was congested. E) Bone marrow showed severe depletion in the erythrocytes as well as the other haemoblasts, 7 day old SPF chick inoculated with CLEVB-Zag2 CAV. (HE, 160 X). Fig. 11 . Histopathological findings of the liver. A) Focal lymphoid cell aggregations in the hepatic parenchyma. B) Severe dilatation and congestion in the portal vein. C) Thymus showed depletion in both cortical and medullary lymphoid structure. D) Spleen showed focal necrosis in diffuse manner allover the white pulps. E) The bone marrow showed severe depletion in diffuse manner allover the erythrocytes as well as the haemoblasts with inflammatory cells infiltration, at the 14th day PI (HE, 160X). 
Conclusion
The present study showed that the CLEVB-Zag2 CAV isolate is highly pathogenic and immunosuppressive virus. Moreover, our results suggest that further studies on the CIA vaccine are needed to elucidate the relationship between vaccine efficacy and wild strains as well as further studies related to reversion of vaccine virus to virulence.
